Hilden, DE, United States of America

Schorr Joachim

This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 2004.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Schorr Joachim: Innovator in Immunization and Gene Therapy

Introduction

Schorr Joachim is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of immunization and gene therapy through his innovative research and patents. His work focuses on improving DNA vaccine vectors and therapeutic protocols.

Latest Patents

Schorr Joachim holds 1 patent for his invention titled "Vectors and methods for immunization or therapeutic protocols." This patent demonstrates that DNA vaccine vectors can be enhanced by the removal of CpG-N motifs and the optional addition of CpG-S motifs. Furthermore, for sustained expression levels, the optimized vector should incorporate a promoter/enhancer that remains unaffected by the cytokines induced by the immunostimulatory CpG motifs. The invention also provides improved gene therapy vectors by identifying and modifying the CpG motifs present in the construct, thereby enhancing the expression of therapeutic polypeptides.

Career Highlights

Schorr Joachim is associated with the University of Iowa Research Foundation, where he continues to advance his research in immunization and gene therapy. His work has implications for developing more effective vaccines and therapeutic strategies.

Collaborations

He has collaborated with notable researchers such as Arthur Mertz Krieg and Heather Lynn Davis, contributing to the advancement of knowledge in his field.

Conclusion

Schorr Joachim's innovative work in the realm of immunization and gene therapy showcases his commitment to enhancing medical science. His contributions are paving the way for future advancements in vaccine development and therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…